Phase II Trial of Temozolomide (TMZ), Motexafin Gadolinium (MGd), and 60 Gy Fractionated Radiation (RT) for Newly Diagnosed Supratentorial Glioblastoma (GBM): Results of RTOG 0513 von Brachman, D.G, Wang, M, Ashby, L.S, Thomas, T.A, Dunbar, E.M, Rockhill, J.K, Khuntia, D, Bovi, J.A, Macher, M.S, Mehta, M.P

Volltext

Results of phase II trial of SL-701, a novel immunotherapy targeting IL-13Ra2, EphA2, and survivin, in adults with second-line recurrent glioblastoma (GBM) von Peereboom, D., Nabors, L.B., Kumthekar, P., Badruddoja, M., Fink, K., Lieberman, F., Phuphanich, S., Dunbar, E., Walbert, T., Schiff, D., Tran, D.D., Ashby, L.S., Butowski, N., Iwamoto, F., Lindsay, R., Bullington, J., Schulder, M., Sherman, J., Brooks, C., Reardon, D.

Volltext

Joint Final Report of EORTC 26951 and RTOG 9402: phase III trials with procarbazine, lomustine, and vincristine chemotherapy for anaplastic oligodendroglial tumors von Lassman, A.B., Hoang-Xuan, K., Polley, M.Y.C., Brandes, A.A., Cairncross, J.G., Kros, J.M., Ashby, L.S., Taphoorn, M.J.B., Souhami, L., Dinjens, W.N.M., Laack, N.N., Kouwenhoven, M.C.M., Fink, K.L., French, P.J., Macdonald, D.R., Lacombe, D., Won, M., Gorlia, T., Mehta, M.P., Bent, M.J. van den

Volltext bestellen

Mechanistic insight into biopolymer induced iron oxide mineralization through quantification of molecular bonding von Sand, K. K, Jelavi, S, Dobberschütz, S, Ashby, P. D, Marshall, M. J, Dideriksen, K, Stipp, S. L. S, Kerisit, S. N, Friddle, R. W, DeYoreo, J. J

Volltext

Assays to predict the genotoxicity of the chromosomal mutagen etoposide — focussing on the best assay von Turner, S.D, Wijnhoven, S.W.P, Tinwell, H, Lashford, L.S, Rafferty, J.A, Ashby, J, Vrieling, H, Fairbairn, L.J

Volltext

A survey of sap-transmissible viruses of lucerne in New Zealand von Ashby, J. W., Forster, R. L. S., Fletcher, J. D., Teh, P. B.

Volltext

A multi-coil magnetic probe von Ashby, D E T F, Holmes, L S, Kasha, M A

Volltext